2002
DOI: 10.1016/s0304-3835(02)00435-4
|View full text |Cite
|
Sign up to set email alerts
|

Gender differences in the dihydropyrimidine dehydrogenase expression of colorectal cancers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
12
0
1

Year Published

2003
2003
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(15 citation statements)
references
References 15 publications
2
12
0
1
Order By: Relevance
“…In our series, the DPD protein level in CRC was lower in women than in men, consistent with the results of Yamashita et al [13] , who found that colonic tumors were more common in women than in men, whereas protein expression levels of DPD in both colonic and rectal tumors were lower in women. In the present study, the DPD protein expression level was significantly lower in colonic tumors than in rectal tumors, but there was no significant gender-related difference in the location of primary tumors (data not shown).…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…In our series, the DPD protein level in CRC was lower in women than in men, consistent with the results of Yamashita et al [13] , who found that colonic tumors were more common in women than in men, whereas protein expression levels of DPD in both colonic and rectal tumors were lower in women. In the present study, the DPD protein expression level was significantly lower in colonic tumors than in rectal tumors, but there was no significant gender-related difference in the location of primary tumors (data not shown).…”
Section: Discussionsupporting
confidence: 92%
“…When the tumors in our series were classified according to histopathological type, DPD levels in poorly differentiated, mucinous and signet ring cell tumors were significantly higher than those in well-and moderately differentiated tumors. In contrast, Yamashita et al [13] and Shirota et al [16] demonstrated no significant difference in DPD protein or mRNA expression levels according to histopathological type in CRC. In primary gastric cancer, Ichikawa et al [17] reported that TS and DPD mRNA expression levels differ according to the degree of tumor differentiation.…”
Section: Discussionmentioning
confidence: 89%
“…However, there were no significant differences in treatment-related deaths according to BMI class (P ϭ 0.99). Although reports of differences in 5-FU toxicity according to patient gender have been reported, 38 the differences in treatment-related toxicity according to BMI class were similar for both men and women.…”
Section: Treatment-related Toxicity By Body Mass Index Classmentioning
confidence: 74%
“…Bei Frauen wurde im Tumorgewebe deutlich weniger DPD exprimiert, verglichen mit den Gewebeproben aus der gesunden Darmwand (p = 0,0002). Frauen sprechen deshalb wahrscheinlich besser auf die Therapie mit 5-FU an als Männer, die keinen Unterschied in der DPD-Expression aufwiesen [53]. Andererseits ist bei erhöhter Bioverfügbarkeit von 5-FU an eine mögliche Kardiotoxizität zu denken.…”
Section: Rezidivrate Und Rezidivmusterunclassified